UnitedHealth Group (LIM:UNH) Research & Development: $0 Mil (TTM As of Mar. 2026)


LIM:UNH UnitedHealth Group Inc LIM:UNH
66 GF Score
Price $415.00
GF Value $603.41
Valuation Significantly Undervalued
! 10 Warning Signs
View Full Analysis

What is UnitedHealth Group Research & Development?

UnitedHealth Group LIM:UNH +2.98% 66 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates LIM:UNH with a GF Score™ of 66/100 and a GF Value™ of $603.41 (Significantly Undervalued). The stock has 10 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. UnitedHealth Group's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

UnitedHealth Group  (LIM:UNH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

UnitedHealth Group Research & Development Related Terms

UnitedHealth Group Research & Development Historical Data

* Premium members only.

The historical data trend for UnitedHealth Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UnitedHealth Group Research & Development Chart

UnitedHealth Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

UnitedHealth Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LIM:UNH
66GF Score
UnitedHealth Group Inc LIM:UNH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UnitedHealth Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
UnitedHealth Group (LIM:UNH) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on UnitedHealth Group and its competitors.
Is UnitedHealth Group's Research & Development too high?
UnitedHealth Group's current Research & Development is $0 Mil. Overall, UnitedHealth Group has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnitedHealth Group's Research & Development compare to CVS and ELV?
UnitedHealth Group's Research & Development of $0 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Plans company?
A good Research & Development depends on the Healthcare Plans industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on UnitedHealth Group and its competitors. UnitedHealth Group's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnitedHealth Group stock overvalued right now?
Based on GuruFocus' analysis, UnitedHealth Group (LIM:UNH) is currently considered Significantly Undervalued. The stock's GF Value™ is $603.41, compared to a current price of $415.00 — trading 31.2% below its estimated fair value. The current Research & Development is $0 Mil. UnitedHealth Group's overall GF Score™ is 66/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For UnitedHealth Group (LIM:UNH), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UnitedHealth Group (LIM:UNH) Overvalued in 2026?

Based on GuruFocus' analysis, UnitedHealth Group stock appears to be undervalued. The current stock price of $415.00 is trading 31.2% below its estimated GF Value™ of $603.41. GuruFocus considers UnitedHealth Group to be Significantly Undervalued.

Key valuation signals for LIM:UNH:

  • Research & Development: $0 Mil
  • GF Value™: $603.41 vs. price of $415.00 (31.2% below fair value)
  • GF Score™: 66/100 with 10 warning signs

No single metric tells the full story. See the LIM:UNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UnitedHealth Group Business Description

Address 1 Health Drive, Eden Prairie, MN, USA, 55344
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
66GF Score

Get the complete analysis for LIM:UNH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$415.00
Price
$603.41
GF Value